Corrigendum to: Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study (Pharmacoepidemiology and Drug Safety, (2018), 27, 2, (174-181), 10.1002/pds.4350)

Anton Pottegård, Erik L Grove, Maja Hellfritzsch Poulsen

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

    19 Downloads (Pure)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Corrigendum to: Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study (Pharmacoepidemiology and Drug Safety, (2018), 27, 2, (174-181), 10.1002/pds.4350)'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab